{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:01:59Z","timestamp":1788829319824,"version":"build-2803163510"},"reference-count":97,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T00:00:00Z","timestamp":1683417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmune bullous diseases (AIBDs) are a group of rare blistering dermatoses of the mucous membrane and\/or skin. The efficacy, safety and treatment durability of intravenous immunoglobulin (IVIg) as an alternative treatment should be explored to systematically review the available literature regarding treatment outcomes with IVIg in AIBD patients. The predefined search strategy was incorporated into the following database, MEDLINE\/PubMed, Embase, Scopus and Web of Science on 18 July 2022. Sixty studies were enrolled using Preferred Reporting Items for Systematic Reviews and Meta\u2010analyses guidelines. The use of IVIg alone or combined with rituximab was reported in 500 patients with pemphigus, 82 patients with bullous pemphigoid, 146 patients with mucous membranes pemphigoid and 19 patients with epidermolysis bullosa acquisita. Disease remission with IVIg therapy and RTX\u2009+\u2009IVIg combination therapy were recorded as 82.8% and 86.7% in pemphigus, 88.0% and 100% in bullous pemphigoid and 91.3% and 75.0% in mucous membrane pemphigoid, respectively. In epidermolysis bullosa acquisita, treatment with IVIg led to 78.6% disease remission; no data were available regarding the treatment with RTX\u2009+\u2009IVIg in this group of patients. Among all the included patients, 37.5% experienced at least one IVIg\u2010related side effect; the most common ones were headaches, fever\/chills and nausea\/vomiting. The use of IVIg with or without rituximab had a favourable clinical response in patients with AIBDs. IVIg has no major influence on the normal immune system, which makes its utilization for patients with AIBDs reasonable.<\/jats:p>","DOI":"10.1111\/exd.14829","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:49:15Z","timestamp":1683506955000},"page":"934-944","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy"],"prefix":"10.1111","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-0598","authenticated-orcid":false,"given":"Nika","family":"Kianfar","sequence":"first","affiliation":[{"name":"Department of Dermatology, Razi Dermatology Hospital, Autoimmune Bullous Diseases Research Center, School of Medicine Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Dasdar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Razi Dermatology Hospital, Autoimmune Bullous Diseases Research Center, School of Medicine Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Daneshpazhooh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Razi Dermatology Hospital, Autoimmune Bullous Diseases Research Center, School of Medicine Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-1458","authenticated-orcid":false,"given":"Zeinab","family":"Aryanian","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Razi Dermatology Hospital, Autoimmune Bullous Diseases Research Center, School of Medicine Tehran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-4429","authenticated-orcid":false,"given":"Azadeh","family":"Goodarzi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine Iran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,5,7]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13637"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01974"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.047"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17465"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000056"},{"key":"e_1_2_11_8_1","volume-title":"Corticosteroid Adverse Effects","author":"Yasir M","year":"2018"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15902"},{"issue":"6","key":"e_1_2_11_10_1","first-page":"964","article-title":"Bullous pemphigoid and intravenous gammaglobulin","volume":"103","author":"Godard W","year":"1985","journal-title":"Ann Intern Med"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1670059"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.10.034"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18538"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15672"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.005"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.12.043"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000609"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01090"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.06.036"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.174.5.1741241"},{"key":"e_1_2_11_21_1","unstructured":"The Centre for Evidence\u2010Based Medicine. Levels of evidence.2009. Accessed February 4 2021.https:\/\/www.cebm.ox.ac.uk\/resources\/levels\u2010of\u2010evidence\/oxford\u2010centre\u2010for\u2010evidence\u2010based\u2010medicine\u2010levels\u2010of\u2010evidence\u2010march\u20102009."},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.052"},{"issue":"12","key":"e_1_2_11_23_1","first-page":"13030","article-title":"Rituximab and intravenous immunoglobulin as alternatives to long\u2010term systemic corticosteroids in the treatment of pemphigus: a single center case series of 63 patients","volume":"23","author":"Brown AE","year":"2018","journal-title":"Dermatol Online J"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14143"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1484873"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14955"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01637.x"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.116339"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.116338"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1158"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2002.5278"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.122735"},{"issue":"1","key":"e_1_2_11_33_1","first-page":"48","article-title":"Serum levels of autoantibodies to desmoglein 3 in patients with therapy\u2010resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins","volume":"84","author":"Herzog S","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600972016"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01540.x"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2006.00053"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.007"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809050-00007"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.503"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.001"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10658.x"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12280"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062930"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1508234"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12422"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.02.013"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.4103\/ejdv.ejdv_39_17"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2016.11.003"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.11.030"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.116337"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00714.x"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1717"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.137.9.1181"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.11.002"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.09.049"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01942.x"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1076\/0271-3683(200008)2121-VFT646"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2001.5150"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90496-7"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.11.012"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2004.04.010"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14873"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1433302"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.10.029"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8372146"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3603-3"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002080"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1801974"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04205.x"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1179711"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02817.x"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.06.029"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001024"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1471"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3662"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K198"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)62956-X"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)80148-3"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02631.x"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200708050-00004"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13059"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106385"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-66884-0_39"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2011.606452"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-00092-2"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.012"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0290"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01037-3"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002036"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656362"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003501"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.928621"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.12.056"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.06.007"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0896-1"},{"issue":"6","key":"e_1_2_11_96_1","first-page":"403","article-title":"Deep venous thrombosis after high\u2010dose intravenous immunoglobulin in the treatment of pemphigus vulgaris","volume":"73","author":"Sheehan DJ","year":"2004","journal-title":"Cutis"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.8.991"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01299"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/exd.14829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:36:25Z","timestamp":1692286585000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/exd.14829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,7]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1111\/exd.14829"],"URL":"https:\/\/doi.org\/10.1111\/exd.14829","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,7]]},"assertion":[{"value":"2023-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}